| abstract |
A tablet comprising: (a) 1-40% weight: weight of amorphous atorvastatin or a pharmaceutically acceptable salt thereof; (b) 5-10% disintegrating agent; (c) 0-10% binder; (d) 0.2-2% lubricant; and (e) the remainder, diluent; said tablet being prepared by compression without granulation step; with the proviso that the tablet does not contain a concentration of 1.2% to less than about 5%, of an additive of an alkali metal salt. |